203 related articles for article (PubMed ID: 8564847)
1. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.
Lacronique V; Mignon A; Fabre M; Viollet B; Rouquet N; Molina T; Porteu A; Henrion A; Bouscary D; Varlet P; Joulin V; Kahn A
Nat Med; 1996 Jan; 2(1):80-6. PubMed ID: 8564847
[TBL] [Abstract][Full Text] [Related]
2. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.
Rodriguez I; Matsuura K; Khatib K; Reed JC; Nagata S; Vassalli P
J Exp Med; 1996 Mar; 183(3):1031-6. PubMed ID: 8642244
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor alpha protects against Fas-mediated liver apoptosis in mice.
Kanda D; Takagi H; Toyoda M; Horiguchi N; Nakajima H; Otsuka T; Mori M
FEBS Lett; 2002 May; 519(1-3):11-5. PubMed ID: 12023010
[TBL] [Abstract][Full Text] [Related]
4. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
de la Coste A; Fabre M; McDonell N; Porteu A; Gilgenkrantz H; Perret C; Kahn A; Mignon A
Am J Physiol; 1999 Sep; 277(3):G702-8. PubMed ID: 10484397
[TBL] [Abstract][Full Text] [Related]
5. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
Hatano E; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor.
Kosai K; Matsumoto K; Nagata S; Tsujimoto Y; Nakamura T
Biochem Biophys Res Commun; 1998 Mar; 244(3):683-90. PubMed ID: 9535725
[TBL] [Abstract][Full Text] [Related]
8. A Bcl-2 transgene expressed in hepatocytes does not protect mice from fulminant liver destruction induced by Fas ligand.
Loo Gv; Lippens S; Hahne M; Matthijssens F; Declercq W; Saelens X; Vandenabeele P
Cytokine; 2003 May; 22(3-4):62-70. PubMed ID: 12849704
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.
Strasser A; Harris AW; Huang DC; Krammer PH; Cory S
EMBO J; 1995 Dec; 14(24):6136-47. PubMed ID: 8557033
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines.
Hara I; Hara S; Miyake H; Arakawa S; Kamidono S
Int J Oncol; 2001 Jun; 18(6):1181-5. PubMed ID: 11351249
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.
Conway EM; Pollefeyt S; Steiner-Mosonyi M; Luo W; Devriese A; Lupu F; Bono F; Leducq N; Dol F; Schaeffer P; Collen D; Herbert JM
Gastroenterology; 2002 Aug; 123(2):619-31. PubMed ID: 12145814
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.
Iwai K; Miyawaki T; Takizawa T; Konno A; Ohta K; Yachie A; Seki H; Taniguchi N
Blood; 1994 Aug; 84(4):1201-8. PubMed ID: 7519477
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis.
Takahashi M; Saito H; Okuyama T; Miyashita T; Kosuga M; Sumisa F; Yamada M; Ebinuma H; Ishii H
J Hepatol; 1999 Aug; 31(2):315-22. PubMed ID: 10453946
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis by a cytosolic extract from Fas-activated cells.
Enari M; Hase A; Nagata S
EMBO J; 1995 Nov; 14(21):5201-8. PubMed ID: 7489709
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.
Matsuki Y; Li L; Hsu HC; Yang PA; Zheng R; Edwards CK; Chaudry IH; Zhang HG; Mountz JD
Cell Death Differ; 2002 Jun; 9(6):626-35. PubMed ID: 12032671
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Fas ligand-induced apoptosis by TNF.
Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
[TBL] [Abstract][Full Text] [Related]
18. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
Toda I; Wickham LA; Sullivan DA
Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
[TBL] [Abstract][Full Text] [Related]
19. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).
Huang DC; Hahne M; Schroeter M; Frei K; Fontana A; Villunger A; Newton K; Tschopp J; Strasser A
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14871-6. PubMed ID: 10611305
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
